NCT04469426

Brief Summary

After surgery for rectal cancer, many people undergo changes in bowel habits, which may include the need to empty their bowels more often, accidental leakage of stool or gas, the sudden urge to go to the bathroom, and more. The term "Low Anterior Resection Syndrome" or LARS is used to describe these symptoms. LARS has a negative impact on one's quality of life, and can lead to frustration, as there is no single intervention that has proven to be effective for LARS, and each patient has to undergo trial and error to find one's solution. As people struggle with LARS, they describe feeling hopeless and isolated. Peer support is a supportive relationship between individuals who share common experiences or face similar challenges. The goal of our study is to evaluate whether use of an online peer support application with trained mentors who themselves have lived or are living with LARS will empower patients to better manage their LARS symptoms and improve their quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2024

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

2.2 years

First QC Date

March 23, 2020

Last Update Submit

November 26, 2024

Conditions

Keywords

colorectal surgerypeer support

Outcome Measures

Primary Outcomes (2)

  • European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire - C30 questionnaire

    Questionnaire measures baseline quality of life before app use. Maximum score 100 (better function, quality of life). Minimum score 0 (worse function, quality of life).

    1 week before the launch of the app

  • Assessing 'Change' via European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire - C30 questionnaire after 6 months

    Questionnaire measures change in quality of life after app use. Maximum score 100 (better function, quality of life). Minimum score 0 (worse function, quality of life).

    6 months after using the app.

Secondary Outcomes (4)

  • Patient activation measures

    1 week before the launch of the app

  • Change in Patient activation measures

    6 months after using the app.

  • Bowel function Low Anterior Resection Syndrome score

    1 week before the launch of the app

  • Bowel function Low Anterior Resection Syndrome score

    6 months after using the app.

Study Arms (2)

Informational online app group

EXPERIMENTAL

Participants will have access to an interactive online peer support app developed by the research team.

Other: Interactive online informational and peer support app

Booklet only

NO INTERVENTION

Participants will only have access to the educational booklet on LARS developed by the colorectal research team.

Interventions

The app contains LARS information, bowel function diaries, and online platform with trained peer support mentor

Informational online app group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • underwent restorative protectomy for Neo-plastic disease of the rectum
  • completed all treatment within the last 3 years
  • patients with minor or major LARS as defined with the LARS score.

You may not qualify if:

  • Active chemotherapy or radiotherapy
  • Major colonic resection in addition to protectomy
  • Cannot be contacted by telephone
  • Unable to read and comprehend English/French
  • Does not have the appropriate interface to access the app
  • Unable to give clear and informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

St Paul's Hospital

Vancouver, British Columbia, V6Z 1Y6, Canada

Location

Mount Sinai Hospital

Toronto, Ontario, Canada

Location

University Health Network

Toronto, Ontario, Canada

Location

Jewish General Hospital

Montreal, Quebec, H3T1E2, Canada

Location

McGill University Health Centre

Montreal, Quebec, Canada

Location

MeSH Terms

Conditions

Patient ParticipationLow Anterior Resection SyndromeColonic NeoplasmsPatient SatisfactionBehavior

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesRectal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 23, 2020

First Posted

July 14, 2020

Study Start

August 15, 2020

Primary Completion

October 31, 2022

Study Completion

November 12, 2024

Last Updated

November 29, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations